IRIS Accounts Production v23.3.0.418 07795151 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false true false 33 33 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh077951512022-03-31077951512023-03-31077951512022-04-012023-03-31077951512021-03-31077951512021-04-012022-03-31077951512022-03-3107795151ns10:Originalns15:EnglandWales2022-04-012023-03-3107795151ns14:PoundSterlingns10:Original2022-04-012023-03-3107795151ns10:Originalns10:Director12022-04-012023-03-3107795151ns10:Original2022-04-012023-03-3107795151ns10:Original2023-03-3107795151ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3107795151ns10:Originalns10:SmallEntities2022-04-012023-03-3107795151ns10:Originalns10:AuditExemptWithAccountantsReport2022-04-012023-03-3107795151ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3107795151ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3107795151ns10:Originalns10:AbridgedAccounts2022-04-012023-03-3107795151ns10:Original12022-04-012023-03-3107795151ns10:Original41ns10:Director12022-04-012023-03-3107795151ns10:Originalns10:Director22022-04-012023-03-3107795151ns10:Originalns10:RegisteredOffice2022-04-012023-03-3107795151ns10:Original2022-03-3107795151ns10:Originalns5:CurrentFinancialInstruments2023-03-3107795151ns10:Originalns5:CurrentFinancialInstruments2022-03-3107795151ns10:Originalns5:Non-currentFinancialInstruments2023-03-3107795151ns10:Originalns5:Non-currentFinancialInstruments2022-03-3107795151ns5:ShareCapitalns10:Original2023-03-3107795151ns5:ShareCapitalns10:Original2022-03-3107795151ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3107795151ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3107795151ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-04-012023-03-3107795151ns10:Originalns5:PatentsTrademarksLicencesConcessionsSimilar2022-04-012023-03-3107795151ns10:Originalns5:PlantMachinery2022-04-012023-03-3107795151ns10:Originalns5:FurnitureFittings2022-04-012023-03-3107795151ns10:Originalns5:MotorVehicles2022-04-012023-03-3107795151ns10:Originalns5:ComputerEquipment2022-04-012023-03-3107795151ns10:Original2021-04-012022-03-3107795151ns10:Original2022-03-3107795151ns10:Originalns10:Director222022-03-3107795151ns10:Originalns10:Director222021-03-3107795151ns10:Originalns10:Director222022-04-012023-03-3107795151ns10:Originalns10:Director222021-04-012022-03-3107795151ns10:Originalns10:Director222023-03-3107795151ns10:Originalns10:Director222022-03-31
REGISTERED NUMBER: 07795151 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31 March 2023

for

WINNARD MEDICAL SERVICES LTD

WINNARD MEDICAL SERVICES LTD (REGISTERED NUMBER: 07795151)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4

Accountants' Report 7

WINNARD MEDICAL SERVICES LTD

Company Information
for the Year Ended 31 March 2023







Directors: J A Winnard
J L Winnard





Registered office: 43 Coniscliffe Road
Darlington
Co. Durham
DL3 7EH





Registered number: 07795151 (England and Wales)





Accountants: Mitchell Gordon LLP
43 Coniscliffe Road
Darlington
Co. Durham
DL3 7EH

WINNARD MEDICAL SERVICES LTD (REGISTERED NUMBER: 07795151)

Abridged Balance Sheet
31 March 2023

31/3/23 31/3/22
Notes £    £    £    £   
Fixed assets
Intangible assets 4 605 -
Tangible assets 5 45,886 8,507
46,491 8,507

Current assets
Debtors 11,201 542
Cash at bank 60,281 65,131
71,482 65,673
Creditors
Amounts falling due within one year 9,565 11,881
Net current assets 61,917 53,792
Total assets less current liabilities 108,408 62,299

Creditors
Amounts falling due after more than one
year

(13,776

)

-

Provisions for liabilities (8,719 ) (1,617 )
Net assets 85,913 60,682

Capital and reserves
Called up share capital 200 200
Retained earnings 85,713 60,482
Shareholders' funds 85,913 60,682

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WINNARD MEDICAL SERVICES LTD (REGISTERED NUMBER: 07795151)

Abridged Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 March 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 October 2023 and were signed on its behalf by:





J A Winnard - Director


WINNARD MEDICAL SERVICES LTD (REGISTERED NUMBER: 07795151)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Winnard Medical Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on the going concern basis of accounting.

Turnover
Turnover represents the value of work carried out during the year including amounts not yet invoiced, excluding value added tax.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 25% on cost and 10% on cost
Fixtures and fittings - 10% on cost
Motor vehicles - 25% on reducing balance
Computer equipment - At varying rates

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

WINNARD MEDICAL SERVICES LTD (REGISTERED NUMBER: 07795151)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
Additions 615
At 31 March 2023 615
AMORTISATION
Amortisation for year 10
At 31 March 2023 10
NET BOOK VALUE

At 31 March 2023 605

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2022 21,006
Additions 47,958
Disposals (5,680 )
At 31 March 2023 63,284
DEPRECIATION
At 1 April 2022 12,499
Charge for year 9,708
Eliminated on disposal (4,809 )
At 31 March 2023 17,398
NET BOOK VALUE
At 31 March 2023 45,886
At 31 March 2022 8,507

WINNARD MEDICAL SERVICES LTD (REGISTERED NUMBER: 07795151)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

5. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Totals
£   
COST
Additions 43,652
At 31 March 2023 43,652
DEPRECIATION
Charge for year 4,515
At 31 March 2023 4,515
NET BOOK VALUE
At 31 March 2023 39,137

6. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2023 and 31 March 2022:

31/3/23 31/3/22
£    £   
J L Winnard and J A Winnard
Balance outstanding at start of year - -
Amounts advanced 33 -
Amounts repaid (33 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

The balance is interest free and is repayable on demand.

Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Winnard Medical Services Ltd

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Abridged Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Winnard Medical Services Ltd for the year ended 31 March 2023 which comprise the Abridged Income Statement, Abridged Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the Board of Directors of Winnard Medical Services Ltd, as a body, in accordance with the terms of our engagement letter dated 20 September 2022. Our work has been undertaken solely to prepare for your approval the financial statements of Winnard Medical Services Ltd and state those matters that we have agreed to state to the Board of Directors of Winnard Medical Services Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Winnard Medical Services Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Winnard Medical Services Ltd. You consider that Winnard Medical Services Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Winnard Medical Services Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Mitchell Gordon LLP
43 Coniscliffe Road
Darlington
Co. Durham
DL3 7EH


10 October 2023